In contrast, non-liver fluke-associated cholangiocarcinoma has been shown to harbor high copy-number aberrations, PD-1/PD-L1 expression, epigenetic mutations involving IDH1/2 and BAP-1, and FGFR/PRKA-related gene rearrangement [8,17]. Here, IDH1 is linked to cholangiocarcinoma.